Too lazy to write it all out so I just had AI write it. NFA + DYOR Regards
**Trinity Biotech ($TRIB) has launched a new subsidiary, Trinovium, to aggressively pivot its empty, medical-grade chemical manufacturing lines into making ultra-pure direct-to-chip cooling fluids for AI data centers—allowing them to pump out millions of liters of high-margin fluid with zero new factory costs. While the company is burdened by a heavy $124M debt load and only $2M in cash, their primary lender (Perceptive Advisors) is supportive and actively converting that debt into equity at around $0.50 per share to clean up the balance sheet. Crucially, as of today, TRIB has officially terminated its Yorkville funding line, completely eliminating the constant, toxic penny-stock dilution that previously capped the stock's upward momentum. Facing a strict deadline to boost its market value and regain Nasdaq compliance by August 18, 2026, this low-float narrative lottery ticket has the physical infrastructure entirely ready to go, meaning the stock is built to violently re-rate the exact second they announce their first actual data center contract win.**